Author: The Phage News

Staphylococcus aureus bacteremia (SAB) is a bloodstream infection caused by Staphylococcus aureus, associated with significant morbidity and mortality. Staphylococcus aureus bacteremia (SAB) continues to be a…

Factors governing phage replication and phage transmission in situ are unknown, especially within the confines of the gastrointestinal tract. We are unaware of the…

Phage research is advancing with the progression in technologies and instrumentation. With all these come new insights into phage structure beyond what already exists….

When infected with phages, bacteria exhibit defence mechanisms against phages. Scientists have now discovered “jumbo phages” that “cloak” their genetic material in order to…

BiomX, a company developing natural and engineered phages, has announced positive results in clinical trials. BiomX has announced the safety and efficacy results from…

Phages—viruses that specifically target and eliminate bacteria—offer a highly targeted approach to infection control, reducing the risk of harming beneficial microbiota. With the “silent…

The Targeting Phage Therapy organization has announced the 8th World Conference which will be held on June 10-11, 2025 at DoubleTree by Hilton Berlin…

From the ancient times, turmeric has gained its notoriety as an effective antibacterial, anti-inflammatory, anti-oxidant spice. The yellow compound, curcumin, isolated from rhizomes of…

Two phage-based vaccine candidates for avian influenza (H5N1) developed by Cytophage are now entering preclinical trials. Cytophages’ innovative phage technology uses distinct antigen presentation…

“The Phage Art Competition, 2024” comes to an end and The Phage is excited to announce the finalists. The Competition began on 1-December-2024 and…